Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Genetic Approach May Lead to New Treatments for Digestive Diseases

Page View:


Scientists at the University of Massachusetts Medical School (UMMS) say they have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system. This finding, based on studying calcium ion-controlled pathways in mice, may lead to new treatments for a host of digestive disorders, ranging from common gastroesophageal reflux disease (GERD) to swallowing disorders, incontinence, and pancreatitis.

Medicilon can provide various animal models (including renal failure model, anemia animal model, gastric acid secretion animal model, and gastric ulcer model) to test drug effectiveness according to client needs. We can conduct tests on typical digestive system diseases, including gastric acid secretions, gastric ulcers, and renal failure, using rats as subjects.


    The team’s study (“The Molecular Basis of the Genesis of Basal Tone in Internal Anal Sphincter”) was published in Nature Communications.


    “We are excited about the potential to target identified genes to treat disorders such as reflux and incontinence,” said Ronghua ZhuGe, PhD, associate professor of microbiology and physiological systems and a senior author of the study. “Knowing how these muscles stay contracted for such long periods of time will allow us to develop potential new treatments for these diseases. The next step is to see whether this molecular mechanism in mice also operates in humans.”


Related Articles:

Ancient Gut Genetic Core Program Finding May Lead to New Digestive Disease Therapies

Medicilon Pharmacological Model Service

Jumping Genes May Play An Important Role in GI Cancers

Microbiome-Lax May Relieve Constipation

    The human body, and those of other mammals, contains a number of ring-shaped structures made of smooth muscle encircling openings in hollow organs such as the intestines and bladder that are called sphincters. Smooth muscle is controlled involuntarily, unlike the muscles we use to walk, for example, so that we don’t need to consciously move digested food from stomach to small intestine. Dysfunction in the sphincters, either structurally or functionally, can have severe consequences, leading to diseases that impair the ability of the muscle to contract or relax. This can lead to achalasia, which makes it difficult to swallow, and GERD, which allows stomach acid to enter the esophagus or incontinence of the bowels.


    “A healthy sphincter opens transiently but remains closed most of the time, maintaining a basal tone. This basal tone requires constant generation of force produced by the contraction of smooth muscle cells that make up the sphincters,” said Dr. ZhuGe. “However, the genetics governing how the sphincter smooth muscle stays contracted for such long periods of time remains unknown.”


    Smooth muscle operates by generating force as the muscle motor protein myosin and actin filaments move past each other. This happens after the myosin regulatory light chain (MLC) molecule is turned on via phosphorylation. How much phosphorylation takes place is controlled by the relative amounts of two enzymes—calcium-dependent MLC kinase (MLCK), which promotes phosphorylation, and calcium-independent MLC phosphatase (MLCP), which reverses phosphorylation. Through this process, contraction and relaxation of the muscle are achieved.


    To understand the molecular mechanism responsible for the involuntary and continuous contraction of the sphincter muscle, Dr. ZhuGe and colleagues examined the internal anal sphincter that controls bowel continence in mice. They showed that genetic deletion of the MLCP enzyme in the smooth muscle had no effect on the basal tone of the mouse sphincter, but deletion of MLCK essentially abolishes the basal tone and mice become incontinent as a result.


    “Although previous biochemical studies suggested that lower MLCP activity may be related to the basal tone of this sphincter, our genetic study indicates this doesn’t seem to be the case. It turns out MLCK is essential for the tone formation,” said Dr. ZhuGe. “This prompted us to look for specific calcium signals that regulate MLCK.”


    Co-author Lawrence Lifshitz, Ph.D., associate professor of molecular medicine at UMMS, added that “Calcium signaling is our favorite subject. We originally hypothesized that localized releases of calcium inside the cell, near target ion channels, might do the trick, as we knew that such releases can regulate the contraction of smooth muscle in blood vessels and airways.”


    But experiments showed that these local calcium releases have no direct role in muscle tone. Instead, three types of ion channels act in concert to generate a rise in cytosolic calcium that eventually results in MLCK activation and muscle tone.


    To test this hypothesis, ZhuGe’s group teamed up with Minsheng Zhu, Ph.D., at Nanjing University in China, to generate a line of mice in which one of these channels could be turned off in smooth muscle only. “These mice were a powerful tool for establishing our hypothesis,” said Dr. ZhuGe. “They helped us identify the Tmem16a (also called Ano1) gene as a critical component for basal tone formation and fecal continence. When we were able to turn off the TMEM16A channels in these mice, they lost the majority of the basal tone and became incontinent. “


    Identifying the genes underlying sphincter basal tone is an important step toward understanding sphincter disorders and developing new treatments for them. “The treatment options for fecal incontinence are very limited,” notef Jennifer S. Davids, M.D., assistant professor of surgery at UMMS. “One reason for this is our lack of understanding of the molecular basis of sphincter tone and fecal continence. If we can target specific genes, it’s possible we can improve treatment options.”

Relevant newsRelevant news